Genentech Book - Search Videos

Genentech CEO says aiming for tolerable, affordable obesity drugs

Genentech CEO says aiming for tolerable, affordable obesity drugs

MSNMichele Gershberg,Michael Erman

At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech

At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech

84.4K viewsOct 10, 2024

FacebookGenentech

Genentech | LinkedIn

Genentech | LinkedIn

Genentech Closes Cancer Immunology Department | Immunology

Genentech Closes Cancer Immunology Department | Immunology

Genentech & U.S. Roche

Genentech & U.S. Roche

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin’s lymphoma (NHL). It is also the most common type of NHL, accounting for one out of every three lymphomas and affecting almost 31,000 people in the U.S. Learn more about Lamar’s journey with this condition. | Genentech

23.2K viewsJul 26, 2024

FacebookGenentech

The scientific community has made significant advancements in multiple sclerosis (MS). Today, we know that early treatment may slow the progression of disability, helping people preserve their mental and physical abilities as long as possible. Learn how our understanding of MS disease progression is evolving. | Genentech

The scientific community has made significant advancements in multiple sclerosis (MS). Today, we know that early treatment may slow the progression of disability, helping people preserve their mental and physical abilities as long as possible. Learn how our understanding of MS disease progression is evolving. | Genentech

247.5K viewsJan 25, 2024

FacebookGenentech

When first diagnosed with triple-negative breast cancer, Latasha learned the aggressive disease disproportionately affects African American women. She hopes continued research and disease education will lead to a brighter future for the next generation. | Genentech

55.1K viewsOct 9, 2019

FacebookGenentech

Latasha knew little about triple-negative breast cancer when she was diagnosed. Now, she advocates for disease awareness and education and encourages others to learn more about the complexities of the disease. | Genentech

36.6K viewsOct 22, 2019

FacebookGenentech

Primary progressive multiple sclerosis (MS), a form of MS, requires people living with the condition to constantly adapt their daily routines. Learn from members of the progressive MS community, and their personal journeys with the disease. | Genentech

280.4K views11 months ago

FacebookGenentech

Let’s face it: smoking used to be everywhere. But when it comes to facing lung cancer today, you’ve got more power than you think. We’re teaming up with Genentech to encourage those at risk to get screened for lung cancer. Learn who’s eligible at ScreenYourLungs.org | American Cancer Society

5.2K viewsJul 1, 2021

FacebookAmerican Cancer Society

Nasal polyps is a chronic condition that impacts approximately 13 million Americans and is most common in those who have allergies or asthma. It can cause symptoms like congestion, difficulty breathing through the nose, or loss of smell. Watch the video below to learn more about nasal polyps and potential ways to manage it. | Genentech

101.4K viewsDec 7, 2020

FacebookGenentech

Latasha is living with metastatic triple-negative breast cancer, a unique and complex type of the disease. She shares why it's the little things, like spending time with family, that make her happy and keep her grounded. | Genentech

43.5K viewsOct 17, 2019

FacebookGenentech

YahooDailyTicker

Diagnosed with chronic lymphocytic leukemia (CLL) in 2005, Dr. Brian Koffman faced limited treatment options. Now, nearly two decades later, as co-founder, Executive VP, and Chief Medical Officer of the CLL Society, Brian guides others through the expanded range of therapies that have become available since then. Read more. | Genentech

1.1M viewsJul 26, 2024

FacebookGenentech

Multiple sclerosis affects everyone differently, but one thing is consistent - progression can start early and be unpredictable. Learn how to work with a healthcare provider to better understand and track this progression. | Genentech

148.6K views10 months ago

FacebookGenentech

Hear from inspirational Black women living with multiple sclerosis (MS), advocates and caregivers as they discuss personal experiences with MS. | Genentech

759.9K viewsMay 28, 2024

FacebookGenentech

Dr. Laurie Sehn is a hematologist and clinical professor who often treats people living with diffuse large B-cell lymphoma (DLBCL), the most common form of aggressive non-Hodgkin’s lymphoma. Hear more from her about the disease and the importance of effective therapy when treated for the first time. | Genentech

307K viewsJul 30, 2024

FacebookGenentech

Hear from inspirational Black women who are advocates, caregivers, and living with multiple sclerosis (MS) as they discuss personal experiences with MS. | Genentech

84.2K viewsJan 25, 2024

FacebookGenentech

Listen to our own Fred Brown, Healthcare Market Director, talk about his career at Genentech and how we’re actively working to foster belonging in our workforce. Bring your unique perspective to our diverse team: https://bit.ly/3MBF6mM | Genentech Jobs

110.4K viewsMay 17, 2022

FacebookGenentech Jobs

No two breast cancer journeys are the same, and biomarker testing plays an important role in leading to a more personalized treatment approach from the outset. Megan O’Neil, a breast cancer survivor, shares how biomarker testing helped identify the PIK3CA mutation in her tumor. | Genentech

79.6K viewsDec 12, 2024

FacebookGenentech

Ocrelizumab | Genentech Prescribing & Product Information

genentech-medinfo.com

Genentech: Genentech Goes to Town

Ensuring everyone has access to equitable healthcare requires closing gaps in care, including for rural and underserved communities affected by multiple sclerosis (MS). We recently brought together more than 100 patients, providers and advocates for a community dialogue in Phoenix, Arizona, and heard that limited access to MS specialists continues to pose major challenges for patients and providers alike. When we work together, we can convert community insights into practical, sustainable soluti

72.7K views7 months ago

FacebookGenentech

What Genentech didn't tell us when it came to Dixon

Introducing the new and improved Centennial Way Dog Park! As a part of our annual Genentech Gives Back Week, employees came together to build a playground for our local four-legged friends to run, jump and play. Giving back is core to who we are, and we're proud to partner with the South San Francisco Parks and Recreation Department to make our community a better place for everyone, including our furry companions like Sabi! Learn more about our Gives Back Week tradition: http://spr.ly/6182ADkEu

153.9K views7 months ago

FacebookGenentech

Medra raises $52M, partners with Genentech

mobihealthnews.com

GENENTECH: A Rich History of Chemical Engineering Innovation

For nearly 50 years, our expertise in blood cancer has driven us to turn cutting-edge science into meaningful medical breakthroughs. But innovation alone isn’t enough. We’re relentlessly working to ensure people living with blood cancer can access the treatments they need and meeting them where they are by collaborating closely with community oncologists and advocates across the country to help reduce the burdens of treatment. #BloodCancerAwarenessMonth | Genentech

207.4K views7 months ago

FacebookGenentech

Genentech CEO says aiming for tolerable, affordable obesity drugs

See more